Sandeep Tyagi

Dose optimization of TBI-223 for enhanced therapeutic benefit compared to linezolid in antituberculosis regimen

Discovery of natural-product-derived sequanamycins as potent oral anti-tuberculosis agents

Mechanistic Modeling of Mycobacterium tuberculosis Infection in Murine Models for Drug and Vaccine Efficacy Studies

Mutations in <i>pepQ</i> Confer Low-Level Resistance to Bedaquiline and Clofazimine in Mycobacterium tuberculosis

Targeting DnaN for tuberculosis therapy using novel griselimycins

Contribution of Oxazolidinones to the Efficacy of Novel Regimens Containing Bedaquiline and Pretomanid in a Mouse Model of Tuberculosis

Clofazimine shortens the duration of the first-line treatment regimen for experimental chemotherapy of tuberculosis

Verapamil Increases the Bactericidal Activity of Bedaquiline against Mycobacterium tuberculosis in a Mouse Model

Acceleration of Tuberculosis Treatment by Adjunctive Therapy with Verapamil as an Efflux Inhibitor

Assessment of Clofazimine Activity in a Second-Line Regimen for Tuberculosis in Mice

Modeling early bactericidal activity in murine tuberculosis provides insights into the activity of isoniazid and pyrazinamide